Clinical trial

Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients

NCT05755581

Study summary

ClinicalTrials.gov

Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Hormonal Antineoplastics Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Chemotherapy drug Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-04-01

PhasePHASE1

Conditions

Female Breast Cancerverified · MONDO: female breast carcinoma

Interventions

Hormonal AntineoplasticsDRUG

Chemotherapy drugDRUG

Sponsors & collaborators

Sohag Universitylead sponsor

Mapped research locations

SohagEgypt1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05755581 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.